XNAS · ALEC
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Alector, Inc. Common Stock

Alector, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
$2.36
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Analyst data unavailable at compute time · Sentiment absence reason unknown
ALEC
Alector, Inc. Common Stock
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

40/ 100
Veridion Score
SELL BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ALEC moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ALEC catalysts
About Alector, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2019
Employees
103
Country
US

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.36
Last session
Day high
$2.36
Last session
Day low
$2.36
Last session
Previous close
$2.36
52W high
$3.32
-28.92% from high
52W low
$1.14
56% of range
Market cap
$263.5M
EPS
$-1.0600
Beta
1.12
Shares out
111.7M
Avg volume
1.2M
VWAP
$2.36
Last session
Price history computed in-house
1W
+15.12%
1M
+59.46%
3M
+7.76%
1Y
-6.35%
YTD
+51.28%
SMA 50 $1.75 · above
SMA 200 $1.87 · above
52W position 56%

ALEC overview

Veridion Score
40
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ALEC.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ALEC Form 4 filings
Public disclosures

Congress activity in ALEC

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ALEC in the cached public ledger.

Federal contracts

ALEC contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ALEC in this window.
Lobbying spend

ALEC lobbying filings, year to date.

Registered lobbying filings matched to Alector, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ALEC in this window.
Loading news for ALEC
Analyst ratings
Sovereign unlock shows live analyst consensus for ALEC.
Options
Sovereign unlock shows live options positioning for ALEC.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.